The 8th International Symposium on CAR T-cell therapy ‘CARTday’ is taking place in Lille, France on October 17-18, 2024
cartday.org
CAR-T-DAY retweeted
Practical guidelines and recommendations for infection prophylaxis with CAR T and bispecific antibodies in #MultipleMyeloma from the COMMIT Consortium
onlinelibrary.wiley.com/doi/…
@MeeraMohanMD @End_myeloma @rajshekharucms @SusanBal9 @nsc_natalie @BerdejaJesus #mmsm
CAR-T-DAY retweeted
Immune Effector Cell-Associated Hematotoxicity (ICAHT): EHA/EBMT Consensus Grading and Best Practice Recommendations ashpublications.org/blood/ar…
#CART #bmtsm #immunotherapy #tcellrx #ICAN #CRS #CARTcells #CellTherapy #Gene #Genetherapy
@ASTCT
@CART_Therapy @aljurf100 @SaudiLeukemia
CAR-T-DAY retweeted
The Role of Chimeric Antigen Receptor T-Cell Therapy in the Era of Bis... sciencedirect.com/science/ar…
#CART #bmtsm #CARTcell #immunotherapy #tcellrx #ICAN #CRS #CARTcells #CellTherapy #Gene #Genetherapy
@ASTCT
@CARTTherapy
CAR-T-DAY retweeted
7th French International Symposium
on CAR T Cells (CAR T Day)
September 6th, 7th and 8th, 2023
Organized by the Faculty of Medicine and Lille University Hospital.
Faculté de Médecine – pôle recherche
1 place de Verdun 59000 Lille France
7th French International Symposium
on CAR T Cells (CAR T Day)
September 6th, 7th and 8th, 2023
Organized by the Faculty of Medicine and Lille University Hospital.
Faculté de Médecine – pôle recherche
1 place de Verdun 59000 Lille France
CAR-T-DAY retweeted
The @SanRaffaeleMI experience with splenic irradiation prior to allogeneic transplant with treo-based conditioning for #myelofibrosis in the era of JAK-inhibitors: sciencedirect.com/science/ar…
CAR-T-DAY retweeted
A Simple Prognostic System in Myelofibrosis Patients Undergoing Allogeneic Stem Cell Transplant: A CIBMTR/EBMT analysis ashpublications.org/bloodadv…
CAR-T-DAY retweeted
How I approach optimization of patients at risk of cardiac and pulmonary complications after CAR T-cell therapy loom.ly/VX56SaI






